Key facts
- Notable investors include City Light Capital.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for NeuroVitals
- ·The full record, as it builds
Funding rounds
No funding rounds for NeuroVitals are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About NeuroVitals
Developer of a mental health care platform designed to support the treatment of serious psychiatric conditions by addressing both psychological symptoms and metabolic drivers. The company combines AI-driven personalization with behavioral data and biomarker inputs, incorporates mood logging and lab result tracking, integrates research-based treatment frameworks from academic institutions, and adapts care plans over time based on individual responses, enabling patients with conditions such as OCD, bipolar disorder, and depression to receive structured, data-informed, and continuously optimized mental health support.
- Sector
- Healthcare
- HQ
- Cambridge, MA, United States
- Website
- neurovitalsai.com/
- Ownership
- Privately Held (backing)
NeuroVitals doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in NeuroVitals shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on NeuroVitals in its N-PORT filings yet. We sweep new filings monthly.